Alembic Pharma Updates Authorized Personnel for SEBI Material Disclosures
Alembic Pharmaceuticals Ltd 路 Others (Uncategorized) 路 04 Nov 2026, 8:41 pm
Alembic Pharma Updates Authorized Personnel for SEBI Material Disclosures Alembic Pharmaceuticals Limited鈥檚 Board has updated authorized Key Managerial Personnel contact details under SEBI Listing Regulations, effective 4th Nov'26. Executive Chairman Chirayu Amin, Managing Directors Pranav Amin and Shaunak Amin, and CFO G. Krishnan are authorized to determine event materiality and make stock exchange disclosures. Company Secretary Chirag K. Shukla is authorized to make regulatory disclosures. All personnel are reachable via contact number 0265 6637000.
Original exchange filing (PDF)
More announcements from Alembic Pharmaceuticals Ltd
- Alembic Pharmaceuticals Limited receives USFDA Final Approval for Binimetinib Tablets, 15 mg and 45 mg. 路 15 Nov 2026
- Please find attached herewith the Transcript of Post Results Conference Call held on 4th November, 2026. 路 10 Nov 2026
- Alembic Pharmaceuticals Limited receives USFDA Final Approval for Olopatadine Hydrochloride Ophthalmic Solution USP, 0.7% (OTC). 路 05 Nov 2026
- Please find attached Audio Recording of Investor Call. 路 05 Nov 2026
- Please find attached Press Release 路 04 Nov 2026
- Please find attached Investor Presentation for the Quarter and Half Year Ended September 30, 2026. 路 04 Nov 2026
- Please find attached Press Release for the Quarter and Half Year Ended September 30, 2026. 路 04 Nov 2026
- Please find attached Unaudited Financial Results for the Quarter and Half Year Ended September 30, 2026. 路 04 Nov 2026
